Abstract
Presented is a new approach for assaying the effects of drug candidates against protein targets. Human rhinovirus, HRV14, has been analyzed in the presence of both known and potential antiviral drug agents using enzymatically active mass spectrometer sample plates. The combination of automated mass spectrometry with proteolytic digestion provides for the rapid, high-throughput, and sensitive screening of protein-drug interactions. Multiple drug candidates can be assayed from MALDI sample plates containing 100 wells and, to further increase the number of drugs assayed, multiple drugs can be pooled into each solution (10 candidates per well, 1000 candidates per plate). Wells producing spectra indicative of drug activity can be further analyzed to discern the active compound or be tested with alternative assays.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JALA: Journal of the Association for Laboratory Automation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
